HealthcareStatewide NewsDallas COVID-19 Treating Physician Provides Virus and Vaccine Updates in Interview with Texas Senator

Dr. Peter McCullough, a Dallas physician heavily involved in treatment of COVID-19, talked with Sen. Bob Hall about the spread of the virus, early treatment, and vaccines.
October 18, 2021
Last week, Texas Senator Bob Hall (R-Edgewood) hosted another of his informational COVID-19 update videos featuring Dr. Peter McCullough. The Dallas physician has been a leading expert in the early outpatient treatment of COVID-19 and has testified before both the U.S. Senate and the Texas Senate regarding protocols for prevention and treatment.

“I have five important points I want all Texans to hear about COVID-19,” McCullough began.

First, he stated that the virus can not be spread asymptomatically. He cited a study from Wuhan, China including 10 million people with detailed testing and contact tracing.

Even a representative of the World Health Organization’s (WHO) emerging diseases and zoonosis unit, Dr. Maria Van Kerkhove, stated, “From the data we have, it still seems to be rare that an asymptomatic person actually transmits onward to a secondary individual” at a news briefing in June before the comments were later walked back. 

Second, McCullough said that there is no need for asymptomatic testing to continue. Regular testing of players on athletic teams and students at educational institutions is widely mandated. On June 25, WHO released guidance which included that “Widespread screening of asymptomatic individuals is not a currently recommended strategy due to the significant costs associated with it and the lack of data on its operational effectiveness.”

The Texan Tumbler

The third point McCullough emphasized is that natural immunity for those who have recovered from COVID-19 is “robust, complete, and durable.” He said there are 29 supportive studies showing the superiority of natural immunity, but he knows of no credible studies that show the vaccine would have a positive influence on the already existing immunity.

Conversely, McCullough says there are six studies showing that the vaccine can do harm to the COVID-recovered, so in his clinical judgment, McCullough believes the vaccines are contraindicated for those with natural immunity.

“Our best assets are the COVID-recovered,” McCullough pointed out, saying they can work when other employees fall ill. McCullough recovered from a case of COVID-19 last October and has been treating patients with the virus without contracting it again himself.

An article in the British Medical Journal estimates at least one-third of the American population has recovered from a COVID-19 infection and has natural immunity. 

Fourth, “COVID-19 has always been treatable,” McCullough emphasized. He stated that the supportive data for monoclonal antibodies continues to grow. “When given early, it shows a clear reduction in severe illness, hospitalization, and death.”

McCullough encouraged all Texans to know where the nearby infusion centers are located and to get the infusion early in the virus. “Go early, even if you don’t feel bad,” he said.

Furthermore, McCullough said that povidone-iodine (Betadine) diluted in water has worked well as a preventative measure against coronavirus. It is gargled and swished then spit out twice a day. He also recommended cleaning nasal passages with the diluted solution. If one is allergic to iodine, diluted hydrogen peroxide also works well, he said.

Finally, McCullough turned his attention to the much-discussed COVID-19 vaccines. “Unfortunately, medically speaking, the vaccine program is turning out to be a disaster,” he declared. He said the adverse event reporting system shows over 15,000 deaths and over 20,000 Americans disabled from the vaccines.

A study by Ronald Kostoff showed that the chances of dying after the vaccine are greater than dying of COVID-19. “[T]here are five times the number of deaths attributable to each inoculation [versus] those attributable to COVID-19 in the most vulnerable 65+ demographic.”

In September, the Food and Drug Administration (FDA) vaccine committee voted against a blanket authorization for booster shots, although it did suggest them for the high-risk and elderly populations. 

Results were presented about the efficacy of the vaccine. In long-term care facility residents, the efficacy of the vaccine against infection dropped from 74 to 53 percent with the introduction of the Delta variant. However, the vaccines remain at least 75 percent effective against hospitalization across all adult age populations, according to the data presented to the FDA.


Disclosure: Unlike almost every other media outlet, The Texan is not beholden to any special interests, does not apply for any type of state or federal funding, and relies exclusively on its readers for financial support. If you’d like to become one of the people we’re financially accountable to, click here to subscribe.

Get “KB's Hot Take”

A free bi-weekly commentary on current events by Konni Burton.

Kim Roberts

Kim Roberts is a regional reporter for the Texan in the DFW metroplex area where she has lived for over twenty years. She has a Juris Doctor from Baylor University Law School and a Bachelor's in government from Angelo State University. In her free time, Kim home schools her daughter and coaches high school extemporaneous speaking and apologetics. She has been happily married to her husband for 23 years, has three wonderful children, and two dogs.